DFCM
SGMO

Dark Forest Capital Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Dark Forest Capital Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-38
Closed -$67 – 1360
2023
Q1 		$67 Buy
+38
New +$108 ﹤0.01% 1129
2022
Q1 		– Sell
-729
Closed -$5K – 1711
2021
Q4 		$5K Buy
+729
New +$6.33K ﹤0.01% 1181

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dark Forest Capital Management's SGMO Position: Q2 2023 in Review

Dark Forest Capital Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2023, closing a stake of 38 shares — an estimated $67 sold.

Dark Forest Capital Management first reported a position in SGMO in Q4 2021 and held it in 2 quarters. The position peaked at $5K in Q4 2021. 152 funds tracked by Wall St. Rank hold SGMO as of Q2 2023.

  • Dark Forest Capital Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2023 after selling out during the quarter.
  • Dark Forest Capital Management sold 38 SANGAMO THERAPEUTICS INC shares in Q2 2023, an estimated $67.
  • Dark Forest Capital Management first reported a position in SANGAMO THERAPEUTICS INC in Q4 2021 and held it in 2 quarters.
  • Dark Forest Capital Management's SANGAMO THERAPEUTICS INC position peaked at $5K in Q4 2021.
  • 152 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2023.

Based on Dark Forest Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.